Curaleaf Holdings (CURLF) Other financing activities (2019 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Other financing activities of $258000.0 for Q4 2024, down 93.67% year-on-year from $4.1 million in Q1 2024, and up 2445.45% on a QoQ basis from -$11000.0 in Q3 2024.
Curaleaf Holdings (CURLF) Other financing activities (2019 - 2024) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Other financing activities for 6 consecutive years, with $258000.0 the latest figure, recorded in Q4 2024.
- Quarterly Other financing activities fell 93.67% year-over-year to $258000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $230000.0 (up 21.05% YoY) and the FY2025 annual result came in at $256000.0, up 64.1% from the prior year.
- Other financing activities advanced to $258000.0 in Q4 2024 per CURLF's latest filing, from -$11000.0 in the prior quarter.
- Over the last five years, Other financing activities for CURLF reached as high as $314.6 million in Q1 2021 and fell as low as -$311.9 million in Q2 2021.
- A 5-year average of $398812.5 and a median of $308000.0 in 2020 frame the typical range for Other financing activities.
- The largest YoY upside for Other financing activities was 43532.59% in 2021 against a maximum downside of 197520.25% in 2021.
- Year by year, Other financing activities stood at $1.8 million in 2020, then plunged by 150.9% to -$904000.0 in 2021, then soared by 194.69% to $856000.0 in 2022, then surged by 376.52% to $4.1 million in 2023, then sank by 93.67% to $258000.0 in 2024.
- According to Business Quant data, Other financing activities over the past three periods registered $258000.0, -$11000.0, and $4.1 million for Q4 2024, Q3 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 258,000.00 |
| Dec 31, 2024 | 258,000.00 |
| Sep 30, 2024 | -11,000.00 |
| Sep 30, 2024 | -11,000.00 |
| Dec 31, 2023 | 4.08 Mn |
| Dec 31, 2023 | 4.08 Mn |
| Sep 30, 2023 | -4.10 Mn |
| Sep 30, 2023 | -4.10 Mn |
| Dec 31, 2022 | 856,000.00 |
| Dec 31, 2022 | 856,000.00 |
| Sep 30, 2022 | -649,000.00 |
| Sep 30, 2022 | -649,000.00 |
| Jun 30, 2022 | -242.82 Mn |
| Jun 30, 2022 | -242.82 Mn |
| Mar 31, 2022 | 242.60 Mn |
| Mar 31, 2022 | 242.60 Mn |
| Dec 31, 2021 | -904,000.00 |
| Dec 31, 2021 | -904,000.00 |
| Sep 30, 2021 | 1.39 Mn |
| Sep 30, 2021 | 1.39 Mn |